Apolipoprotein E Genotype Modifies the Phenotype of Alzheimer Disease
- 1 January 2006
- journal article
- other
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 63 (1) , 155-156
- https://doi.org/10.1001/archneur.63.1.155
Abstract
Patients with Alzheimer disease (AD) typically have insidious memory failure followed by impairments in other cognitive domains. However, some patients with AD present with combinations of dyscalculia, dyspraxia, visuoperceptual, visuospatial, and spelling deficits with relatively spared memory—so-called biparietal AD.1,2 These patients often have early age at onset (younger than 65 years old) and posterior cortical atrophy on imaging. The apolipoprotein E (APOE) gene, which exists in 3 allelic forms (ε2, ε3, and ε4), is known to influence susceptibility to development of AD3; possessing an ε4 allele is also associated with earlier disease onset. We were therefore prompted to investigate APOE ε4 frequency in biparietal AD.Keywords
This publication has 4 references indexed in Scilit:
- Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophyNeurology, 2004
- Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 casesBrain, 2000
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumJAMA, 1997
- Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1996